DK0957935T3 - Chlamydia-vacciner og immunogene præparater indeholdende et ydre membran-antigen samt fremgangsmåde til fremstilling deraf - Google Patents

Chlamydia-vacciner og immunogene præparater indeholdende et ydre membran-antigen samt fremgangsmåde til fremstilling deraf

Info

Publication number
DK0957935T3
DK0957935T3 DK97939910T DK97939910T DK0957935T3 DK 0957935 T3 DK0957935 T3 DK 0957935T3 DK 97939910 T DK97939910 T DK 97939910T DK 97939910 T DK97939910 T DK 97939910T DK 0957935 T3 DK0957935 T3 DK 0957935T3
Authority
DK
Denmark
Prior art keywords
outer membrane
chlamydia
membrane antigen
preparation
preparations containing
Prior art date
Application number
DK97939910T
Other languages
English (en)
Inventor
D Murdin Andrew
J Underdown Brian
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Application granted granted Critical
Publication of DK0957935T3 publication Critical patent/DK0957935T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK97939910T 1996-09-12 1997-09-11 Chlamydia-vacciner og immunogene præparater indeholdende et ydre membran-antigen samt fremgangsmåde til fremstilling deraf DK0957935T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/713,236 US6464979B1 (en) 1996-09-12 1996-09-12 Chlamydial vaccines and methods of preparation thereof
PCT/CA1997/000656 WO1998010789A1 (en) 1996-09-12 1997-09-11 Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof

Publications (1)

Publication Number Publication Date
DK0957935T3 true DK0957935T3 (da) 2003-06-23

Family

ID=24865335

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97939910T DK0957935T3 (da) 1996-09-12 1997-09-11 Chlamydia-vacciner og immunogene præparater indeholdende et ydre membran-antigen samt fremgangsmåde til fremstilling deraf

Country Status (10)

Country Link
US (2) US6464979B1 (da)
EP (1) EP0957935B1 (da)
AT (1) ATE234630T1 (da)
AU (1) AU4195897A (da)
CA (1) CA2280037A1 (da)
DE (1) DE69720056T2 (da)
DK (1) DK0957935T3 (da)
ES (1) ES2195169T3 (da)
PT (1) PT957935E (da)
WO (1) WO1998010789A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258532B1 (en) 1997-08-14 2001-07-10 Vanderbilt University Methods for in vitro susceptibility testing of chlamydia
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
US7459524B1 (en) 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
EP1169465B1 (en) 1998-12-04 2006-03-01 University Of Manitoba Two-step immunization procedure against chlamydia infection
CN100365120C (zh) * 1998-12-08 2008-01-30 科里克萨有限公司 用于治疗及诊断衣原体感染的化合物和方法
US6448234B1 (en) 1998-12-08 2002-09-10 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6447779B1 (en) 1998-12-08 2002-09-10 Corixa Corporation Compounds for the diagnosis of Chlamydial infection
US6555115B1 (en) 1998-12-08 2003-04-29 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6432916B1 (en) 1998-12-08 2002-08-13 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
WO2000057187A2 (en) * 1999-03-19 2000-09-28 Vanderbilt University Diagnosis and treatment of multiple sclerosis
DE19939246A1 (de) * 1999-08-19 2001-02-22 Phasys Gmbh M Rückfaltung von Membranproteinen
WO2001046224A2 (en) * 1999-12-22 2001-06-28 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
GB0003217D0 (en) * 2000-02-11 2000-04-05 Yaba Ltd Invention
EP1278855B1 (en) 2000-04-21 2008-03-12 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6919187B2 (en) 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
AUPQ954000A0 (en) * 2000-08-18 2000-09-14 Queensland University Of Technology Novel diagnostic agents and uses therefor
US20030138434A1 (en) * 2001-08-13 2003-07-24 Campbell Robert L. Agents for enhancing the immune response
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
TWI341836B (en) * 2004-03-11 2011-05-11 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
ES2325243B1 (es) * 2008-02-27 2011-05-04 Universidad De Granada Antigeno recombinante.
US20120027793A1 (en) 2009-01-29 2012-02-02 British Columbia Cancer Agency Branch Compositions comprising chlamydia antigens
CN103068837B (zh) 2010-05-28 2015-06-24 斯匹遐生物技术公司 嵌合momp抗原、方法和使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427782A (en) * 1981-03-03 1984-01-24 Caldwell Harlan D Isolation of principal outer membrane protein and antigen of Chlamydia trachomatis
GB8919819D0 (en) * 1989-09-01 1989-10-18 Coopers Animal Health Complexes having adjuvant activity

Also Published As

Publication number Publication date
US6635746B1 (en) 2003-10-21
EP0957935A1 (en) 1999-11-24
CA2280037A1 (en) 1998-03-19
AU4195897A (en) 1998-04-02
WO1998010789A1 (en) 1998-03-19
ES2195169T3 (es) 2003-12-01
PT957935E (pt) 2003-08-29
ATE234630T1 (de) 2003-04-15
EP0957935B1 (en) 2003-03-19
US6464979B1 (en) 2002-10-15
DE69720056T2 (de) 2003-10-30
DE69720056D1 (de) 2003-04-24

Similar Documents

Publication Publication Date Title
DK0957935T3 (da) Chlamydia-vacciner og immunogene præparater indeholdende et ydre membran-antigen samt fremgangsmåde til fremstilling deraf
EP0370573A3 (en) Skin test and test kit for aids
DE69529219T2 (de) Helicobacter proteine und impstoffe
BR9605153B1 (pt) vacina de combinação, e, kit de vacinação.
DK1140165T3 (da) Fordbedrede adjuvanssammensætninger baseret på saponin og dermed tilhörende metoder
EP1170016A3 (en) Urease-based vaccine against helicobacter infection
WO1997001640A3 (en) Vaccines against hepatitis c
DK0835133T3 (da) Rekombinant koppevirus-rabies-præparater og kombinationspræparater samt anvendelser deraf
ATE264911T1 (de) Eine universelle immunmodulatorische cytokin- expressierende zelllinie in wartestelling. entsprechende zusammensetzungen und methoden ihrer herstellung und verwendungen
WO1999002186A3 (en) Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant
WO2002034287A3 (en) Therapeutic vaccine formulations containing chitosan
WO1997047271A3 (en) Cellular vaccines and immunotherapeutics and methods for their preparation
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
BR0013574A (pt) Antìgeno vacina de moraxella
AR012896A1 (es) Polipeptido flge de helicobacter pylori, composicion de vacuna, uso de dicho polipeptido para la fabricacion de composiciones, metodo de diagnostico invitro, y kit de diagnostico para la deteccion de la infeccion por helicobacter pylori
EP1027895A3 (en) Erysipelothrix rhusiopathiae antigens and vaccine compositions
WO2000018429A3 (en) Vaccine based on attenuated $i(haemophilus somnus)
NZ330913A (en) Antigens for preventing and reducing parasite infection and disease
MX9700215A (es) Proteinas y vacunas de helicobacter.
WO1998058954A3 (en) Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens
RU94018276A (ru) Штамм бактерий l.monocytogenes усхи-52, используемый для изготовления листериозной вакцины